Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD

Trial Identifier: PT001004
Sponsor: Pearl Therapeutics, Inc.
NCTID:: NCT03256552
Start Date: January 2015
Primary Completion Date: September 2015
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan, Fukuoka-Ken Fukuoka-shi, Fukuoka-Ken, Japan
Japan, Fukuoka-Ken Iizuka-shi, Fukuoka-Ken, Japan
Japan, Gifu-Ken Mizunami-shi, Gifu-Ken, Japan
Japan, Hokkaido Sapporo-shi, Hokkaido, Japan
Japan, Hyogo Himeji-shi, Hyogo, Japan
Japan, Hyogo-Ken Ako-shi, Hyogo-Ken, Japan
Japan, Hyogo-Ken Kakogawa-shi, Hyogo-Ken, Japan
Japan, Hyogo-Ken Kobe-Shi, Hyogo-Ken, Japan
Japan, Hyogo-Ken Nishinomiya-shi, Hyogo-Ken, Japan
Japan, Ibaraki-Ken Naka-gun, Ibaraki-Ken, Japan
Japan, Kanagawa-Ken Kawasaki-shi, Kanagawa-Ken, Japan
Japan, Kyoto-Fu Kyoto-shi, Kyoto-Fu, Japan
Japan, Okayama-Ken Kasaoka-shi, Okayama-Ken, Japan
Japan, Osaka-Fu Kishiwada-shi, Osaka-Fu, Japan
Japan, Osaka-Fu Osaka-shi, Osaka-Fu, Japan
Japan, Shizuoka-Ken Hamamatsu-shi, Shizuoka-Ken, Japan
Japan, Tokyo-To Chuo-ku, Tokyo-To, Japan
Japan, Tokyo-To Toshima-ku, Tokyo-To, Japan